Author: Tokio X'press
FDA: Eisai ‘s “Rembima” approved as a hepatocellular cancer drug
Tokyo Tech: Multivalent ion diffusion (movement) is remarkably promoted – Development of next generation batteries
Japan’s Skylark Holdings to Ditch Plastic Straws by 2020
The 25 highest-paying jobs in the US, ranked – Glassdoor